---

Trazodone is a weak inhibitor of serotonin reuptake and a potent antagonist of serotonin 5HT2A and 5HT2C receptors. Urinary incontinence is a rare side effect of anti-depressant drugs. Side effects of antidepressants can cause delay in treatment of patient and ultimately non-compliance in patients who take this medicinal drug. Here we present a case of trazodone induced urinary incontinence in a woman at menopause period. The patient was a retired woman with 63 years old. She reported a history of bladder prolapsuse and history of consumption of quetiapine and propranolol. But the patient had no history of other somatic illnesses, drug and urinary incontinence before administering the medicinal drug. Psychiatrist prescrided trazodone with dose of 50 mg, orally per day when appearence of the depression, anxiety and insomnia. But, the patient suddenly suffered from urinary incontinence, despite this situation the patient had continued taking the drug for three days. Due to the uncertainty of the above complications patient, was forced to discontinue the drug and follwoing drug discontinuation the side effect disappeard. After the improvement of the urine incontinence and full recovery, re-treatment was began with the same dose of 50 mg trazodone for the patient, but immediately after drug administration to the patient, urinary incontinence appeared once again. Trazodone can be considered as important factor to cause urinary incontinence. Therefore, this issue should be considered whenever this pharmaceutical drug is prescribed.

---

Background and Objective: Elimination disorders such as nocturnal enuresis, urinary incontinence during the day, and fecal incontinence are common problems in childhood. This study aimed to evaluate the effectiveness of training mothers with the Adler-Dreikurs approach for reducing anxiety in children with elimination disorders.
Methods: This field trial was done in 2021 on the mothers of 20 children with elimination disorders who had been referred to the Pediatric Gastroenterology Clinic in Gorgan with a pretest, posttest, and follow-up approach. At the physician's discretion, the children's problem had no anatomical origin. Urinary incontinence and fecal incontinence in children were identified only by psychological symptoms and functional elimination disorders. The mothers were divided into an experimental group (n=10) and a control group (n=10). The experimental group received the Adler-Dreikurs training program in 12 sessions of 90 minutes. The research instrument was the Spence Children's Anxiety Scale – Parent (SCAS-P) (2001), which was completed by the mothers in three stages: pretest, posttest, and 2-month follow-up. Sub-components of anxiety including generalized anxiety, social phobia, obsessive-compulsive, specific phobia, and separation anxiety were also measured.
Results: Mean general anxiety scores in the pretest, posttest, and follow-up stages were 69.1±4.04, 45.8±6.1, and 47.8±5.94 in the experimental group and 69±6.58, 67.8±4.89, and 67.6±5.59 in the control group, respectively. There was a significant difference in all subcomponents of child anxiety in the posttest and follow-up stages between the experimental group and the control group (P<0.05). This difference was also present during the follow-up period except for the obsessive-compulsive subcomponent.
Conclusion: Training mothers through the Adler-Dreikurs approach can reduce anxiety in children with elimination disorders.